Redefining how
we do science

EFEVRE TECH team - Who We Are

Who We Are

Embracing a multifaceted Research and Development approach EFEVRE TECH focuses in the design, manufacture and retail of prototypes and innovative devices in the fields of Health science, Biology, environment management and alternative energy around the globe. Always having in mind customer needs and necessities!

EFEVRE TECH Commitment to Innovation - Mission

Our Mission

EFEVRE TECH LTD's mission is to provide innovative software solutions and advance R&D in Health Science, Biology, Environment, and Alternative Energy, creating cutting-edge prototypes and devices that cater to global customer needs while inspiring collaboration and progress. 

EFEVRE TECH AI-Powered Automation - Vision

Our Vision

EFEVRE TECH LTD envisions itself as a global leader in research and innovation, fostering strategic partnerships to develop ground-breaking products. Our commitment to a multifaced R&D approach, customer-centric solutions, and worldwide impact will drive progress and inspire a sustainable future. 

Our Journey

  1. 1

    June 2018

    EFEVRE TECH LTD is established as a company

  2. 2

    November 2018

    First Grant Approval as an Innovative Enterprise in Cyprus from the Ministry of Commerce

  3. 3

    May 2019

    European Grant Award for AMGEL Basic Device

  4. 4

    May 2020

    AMGEL Basic Device Prototype was completed and pilot tested at the University of Cyprus

  5. 5

    December 2020

    First Order of the AMGEL Basic Device at Agricultural Research Institute of Cyprus in an open tender

  6. 6

    2022

    Grand Fundings from the Cyprus Research and Innovation Center for new Automation Products

  7. 7

    2023

    Grand Fundings from the Cyprus Research and Innovation Center for five vouchers as collaborators for other companies

  8. 8

    December 2023

    AMGEL 247 Pro Prototype was completed and launch to the market

  9. 9

    February 2024

    Secured and Received an Investment for the development costs of the new AMGEL4TT Device

  10. 10

    December 2024

    Launch of the new AMGEL4TT Device in the field of Molecular Diagnostics

  11. 11

    2024

    ISO Certifications Secured for ISO 9001:2015 and ISO 14001:2015

  12. 12

    2024

    Collaboration with 50 leading scientific institutions in the EU through the establishment of the LIFESPIRIT Community

  13. 13

    2024

    European Patent Approved in 26 countries for AMGEL Technology, including Germany, England and France

  14. 14

    January 2025

    First Order of AMGEL4TT Device delivery at the University of Cambridge in the Automation of New Molecular Diagnostic Methods

  15. 15

    April 2026

    First launch of BioSkepsis, the AI research assistant for life sciences

YOUR NEXT BREAKTHROUGH STARTS HERE

Let’s move your science forward

Tell us what your lab needs. We’ll help you find the right solution.